REPORT ID 483

Global Cancer Gene Therapy Market Research Report 2017

Publish Date
04-Dec-17
Pages
120
Format
Electronic (PDF)

In this report, the global Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Gene Therapy in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Cancer Gene Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Adaptimmune
    GlaxoSmithKline
    Bluebird bio
    Merck
    Celgene
    Shanghai Sunway Biotech
    BioCancell
    Shenzhen SiBiono GeneTech
    SynerGene Therapeutics
    OncoGenex Pharmaceuticals
    Genelux Corporation
    Cell Genesys
    Advantagene
    GenVec
    BioCancell
    Celgene
    Epeius Biotechnologies
    Introgen Therapeutics
    Ziopharm Oncology
    Shenzhen SiBiono GeneTech
    Altor Bioscience
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Gene Induced Immunotherapy
    Oncolytic Virotherapy
    Gene Transfer
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Diagnostics Centers
    Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Cancer Gene Therapy Market Research Report 2017
1 Cancer Gene Therapy Market Overview
    1.1 Product Overview and Scope of Cancer Gene Therapy
    1.2 Cancer Gene Therapy Segment by Type (Product Category)
        1.2.1 Global Cancer Gene Therapy Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Cancer Gene Therapy Production Market Share by Type (Product Category) in 2016
        1.2.3 Gene Induced Immunotherapy
        1.2.4 Oncolytic Virotherapy
        1.2.5 Gene Transfer
    1.3 Global Cancer Gene Therapy Segment by Application
        1.3.1 Cancer Gene Therapy Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Diagnostics Centers
        1.3.4 Research Institutes
    1.4 Global Cancer Gene Therapy Market by Region (2012-2022)
        1.4.1 Global Cancer Gene Therapy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Cancer Gene Therapy (2012-2022)
        1.5.1 Global Cancer Gene Therapy Revenue Status and Outlook (2012-2022)
        1.5.2 Global Cancer Gene Therapy Capacity, Production Status and Outlook (2012-2022)

2 Global Cancer Gene Therapy Market Competition by Manufacturers
    2.1 Global Cancer Gene Therapy Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Cancer Gene Therapy Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Cancer Gene Therapy Production and Share by Manufacturers (2012-2017)
    2.2 Global Cancer Gene Therapy Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Cancer Gene Therapy Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Cancer Gene Therapy Market Competitive Situation and Trends
        2.5.1 Cancer Gene Therapy Market Concentration Rate
        2.5.2 Cancer Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Gene Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Cancer Gene Therapy Capacity and Market Share by Region (2012-2017)
    3.2 Global Cancer Gene Therapy Production and Market Share by Region (2012-2017)
    3.3 Global Cancer Gene Therapy Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Cancer Gene Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Cancer Gene Therapy Consumption by Region (2012-2017)
    4.2 North America Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
    4.4 China Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
    4.7 India Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

5 Global Cancer Gene Therapy Production, Revenue (Value), Price Trend by Type
    5.1 Global Cancer Gene Therapy Production and Market Share by Type (2012-2017)
    5.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
    5.3 Global Cancer Gene Therapy Price by Type (2012-2017)
    5.4 Global Cancer Gene Therapy Production Growth by Type (2012-2017)

6 Global Cancer Gene Therapy Market Analysis by Application
    6.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2012-2017)
    6.2 Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Cancer Gene Therapy Manufacturers Profiles/Analysis
    7.1 Adaptimmune
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Cancer Gene Therapy Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Adaptimmune Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 GlaxoSmithKline
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Cancer Gene Therapy Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 GlaxoSmithKline Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Bluebird bio
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Cancer Gene Therapy Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bluebird bio Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Merck
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Cancer Gene Therapy Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Merck Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Celgene
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Cancer Gene Therapy Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Celgene Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Shanghai Sunway Biotech
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Cancer Gene Therapy Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 BioCancell
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Cancer Gene Therapy Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 BioCancell Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Shenzhen SiBiono GeneTech
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Cancer Gene Therapy Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 SynerGene Therapeutics
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Cancer Gene Therapy Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 SynerGene Therapeutics Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 OncoGenex Pharmaceuticals
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Cancer Gene Therapy Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Genelux Corporation
    7.12 Cell Genesys
    7.13 Advantagene
    7.14 GenVec
    7.15 BioCancell
    7.16 Celgene
    7.17 Epeius Biotechnologies
    7.18 Introgen Therapeutics
    7.19 Ziopharm Oncology
    7.20 Shenzhen SiBiono GeneTech
    7.21 Altor Bioscience

8 Cancer Gene Therapy Manufacturing Cost Analysis
    8.1 Cancer Gene Therapy Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Cancer Gene Therapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Cancer Gene Therapy Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Cancer Gene Therapy Market Forecast (2017-2022)
    12.1 Global Cancer Gene Therapy Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Cancer Gene Therapy Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2017-2022)
    12.2 Global Cancer Gene Therapy Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Cancer Gene Therapy Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Cancer Gene Therapy Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer